Lukas Bubendorf

Active 1996–2025

152
Papers
26,759
Citations
84
h-index
145
i10-index

Citations

Citations per year for Lukas Bubendorf1971: 1 citations1976: 1 citations1983: 1 citations1987: 1 citations1991: 1 citations1996: 2 citations1997: 4 citations1998: 13 citations1999: 38 citations2000: 77 citations2001: 226 citations2002: 304 citations2003: 347 citations2004: 368 citations2005: 301 citations2006: 245 citations2007: 232 citations2008: 225 citations2009: 205 citations2010: 195 citations2011: 203 citations2012: 169 citations2013: 165 citations2014: 171 citations2015: 152 citations2016: 152 citations2017: 127 citations2018: 128 citations2019: 547 citations2020: 691 citations2021: 747 citations2022: 503 citations2023: 397 citations2024: 650 citations2025: 294 citations2026: 12 citations1972–1975: no citations, so these years are not shown1977–1982: no citations, so these years are not shown1984–1986: no citations, so these years are not shown1988–1990: no citations, so these years are not shown1992–1995: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,991 citing papers, 25.2% of this breakdownChina: 1,145 citing papers, 9.6% of this breakdownGermany: 743 citing papers, 6.3% of this breakdownUnited Kingdom: 693 citing papers, 5.8% of this breakdownItaly: 580 citing papers, 4.9% of this breakdownSwitzerland: 491 citing papers, 4.1% of this breakdownCanada: 443 citing papers, 3.7% of this breakdownFrance: 425 citing papers, 3.6% of this breakdownJapan: 373 citing papers, 3.1% of this breakdownSpain: 360 citing papers, 3% of this breakdownNetherlands: 334 citing papers, 2.8% of this breakdownAustralia: 317 citing papers, 2.7% of this breakdown
0%25.2%Other 25.2%

Fields

  • Medicine56.8%
  • Biochemistry, Genetics and Molecular Biology33.8%
  • Computer Science2.4%
  • Immunology and Microbiology1.9%
  • Neuroscience1.1%
  • Materials Science1%
  • Other3%

Topics

  • Lung Cancer Treatments and Mutations4.7%
  • Cancer Immunotherapy and Biomarkers4%
  • Prostate Cancer Treatment and Research3.9%
  • Cancer Genomics and Diagnostics3.2%
  • Lung Cancer Diagnosis and Treatment3.2%
  • Gene expression and cancer classification2.7%
  • Other78.3%

Coauthors

All papers

Open in search
  1. A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Masayuki Noguchi, Claudia Poleri, Natasha Rekhtman, Ming‐Sound Tsao, Erik Thunnissen, William D. Travis, Yasushi Yatabe, Anja C. Roden, Jillian B. Daigneault, Ignacio I. Wistuba, Keith M. Kerr, Harvey I. Pass, Andrew G. Nicholson, Mari Mino–Kenudson - Journal of Thoracic Oncology 2020 cited by 541

  2. IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ugo Pastorino, Luis Paz‐Ares, Giuseppe Pelosi, Claudia Poleri, Mariano Provencio, Anja C. Roden, Giorgio V. Scagliotti, Stephen G. Swisher, Erik Thunnissen, Ming‐Sound Tsao, Johan Vansteenkiste, Walter Weder, Yasushi Yatabe - Journal of Thoracic Oncology 2020 cited by 450

  3. PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Thoracic Oncology 2018 cited by 807

  4. Metastatic patterns of prostate cancer: An autopsy study of 1,589 patients

    Authors: , , , , , , , - Human Pathology 2000 cited by 1,895

  5. The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yasushi Yatabe, Akihiko Yoshida, Jillian B. Daigneault, Ahmet Zehir, Solange Peters, Ignacio I. Wistuba, Keith M. Kerr, John Longshore - Journal of Thoracic Oncology 2020 cited by 292

  6. Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non–Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers

    Authors: , , , , , , , , , , , , , , , , - Clinical Cancer Research 2018 cited by 230

  7. Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2021 cited by 110

  8. Tissue microarrays for high-throughput molecular profiling of tumor specimens

    Authors: , , , , , , , , , - Nature Medicine 1998 cited by 4,135

  9. Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ignacio I. Wistuba, André L. Moreira - Journal of Thoracic Oncology 2018 cited by 353

  10. PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Masayuki Noguchi, Giuseppe Pelosi, Claudia Poleri, William D. Travis, Akihiko Yoshida, Jillian B. Daigneault, Ignacio I. Wistuba, Mari Mino–Kenudson - Journal of Thoracic Oncology 2019 cited by 345

  11. Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation study

    Authors: , , , , , , , , , , , , , , , - Cell Death and Disease 2019 cited by 129

  12. Prostate cancer patient‐derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens

    Authors: , , , , , , , , , , , , , , , - The Journal of Pathology 2021 cited by 80

  13. 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Egbert F. Smit, Peter Meldgaard, Alex A. Adjei, M. Nicolson, Lucio Crinò, Paul Van Schil, Suresh Senan, Corinne Faivre‐Finn, Gaetano Rocco, Paolo Veronesi, Jean-Yves Douillard, Eric Lim, Christophe Dooms, W. Weder, Dirk De Ruysscher, C. Le Péchoux, Paul De Leyn, Virginie Westeel - Annals of Oncology 2014 cited by 495

  14. Memory CD8+ T Cells Balance Pro- and Anti-inflammatory Activity by Reprogramming Cellular Acetate Handling at Sites of Infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Cell Metabolism 2020 cited by 68

  15. Perioperative Chemoimmunotherapy With Durvalumab for Muscle-Invasive Urothelial Carcinoma: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/17

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 cited by 42

  16. 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , M. Nicolson, Lucio Crinò, Paul Van Schil, Suresh Senan, Corinne Faivre‐Finn, Gaetano Rocco, Giulia Veronesi, Jean-Yves Douillard, Eric Lim, Christophe Dooms, Walter Weder, Dirk De Ruysscher, C. Le Péchoux, Paul De Leyn, Virginie Westeel - Annals of Oncology 2015 cited by 398

  17. A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non–muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14

    Authors: , , , , , , , , , , , , , , , , , , , , , , - European Urology Oncology 2022 cited by 38

  18. Prognostic Impact of KRAS G12C Mutation in Patients With NSCLC: Results From the European Thoracic Oncology Platform Lungscape Project

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Thoracic Oncology 2021 cited by 64

  19. Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European Expert Group

    Authors: , , , , , , , , , , , - Thorax 2015 cited by 196

  20. The World Health Organization Reporting System for Lung Cytopathology

    Authors: , , , , , , , , , , , , , , , , , , - Acta Cytologica 2022 cited by 62

  21. Immunocytochemistry for predictive biomarker testing in lung cancer cytology

    Authors: , , , , , , , , , , , , - Cancer Cytopathology 2019 cited by 114

  22. Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers

    Authors: , , , , , , , , , - British Journal of Cancer 2006 cited by 384

  23. Prognostic value of the autophagy markers LC3 and p62/SQSTM1 in early-stage non-small cell lung cancer

    Authors: , , , , , , , , , , - Oncotarget 2016 cited by 135

  24. Gene-Expression Profiles in Hereditary Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2001 cited by 1,744